Key facts
- It has raised $14.3M; the latest was Early Stage VC in Dec 2024.
- Notable investors include Legend Capital, B Capital Group, YuanBio Venture Capital, Dalton Venture.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Macrolux Medical
- ·The full record, as it builds
Funding rounds
No funding rounds for Macrolux Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Macrolux Medical
Developer of endoscopic interventional diagnosis and treatment devices. The company provides endoscopic interventional diagnosis and treatment solutions covering urology, respiratory, and digestive, enabling patients with earlier detection and better treatments.
- Sector
- Healthcare
- HQ
- Shenzhen, China
- Founded
- 2020
- Website
- microlite.cn/
- Ownership
- Privately Held (backing)
Macrolux Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Macrolux Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Macrolux Medical in its N-PORT filings yet. We sweep new filings monthly.